Opna Immuno-Oncology SA (Opna-IO) is a biotechnology company recently spun-off from the Swiss Institute of Experimental Cancer Research within the École Polytechnique Fédérale de Lausanne (EPFL). The Company is developing first in-class therapies to disrupt immuno-suppressive barriers in cancer cells so as to enhance the capability of the body’s immune system to attack human tumors.
Key information
- Biotechnology / Chemistry / Pharmaceutical
- 1 employee
- Ch de Charmilles 34, St. Sulpice
New jobs directly in your mailbox?
Currently, there are no job offers. Follow this company, and we’ll inform you by email as soon as new jobs become available.
No reviews yet
Help others by sharing your experience with this company as an employee or a candidate.